UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )1
|
Assembly Biosciences, Inc.
|
|
(Name of Issuer)
|
|
Common Stock, $0.001 par value
|
|
(Title of Class of Securities)
|
|
045396108
|
|
(CUSIP Number)
|
|
October 1, 2014
|
|
(Date of Event Which Requires Filing of this Statement)
|
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| o | Rule 13d-1(b) |
| x | Rule 13d-1(c) |
| o | Rule 13d-1(d) |
_______________
1 The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP NO. 045396108
|
1
|
NAME OF REPORTING PERSON
EcoR1 Capital Fund, L.P.
|
||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) o
(b) o
|
|
|
3
|
SEC USE ONLY
|
||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
0 shares
|
|
|
6
|
SHARED VOTING POWER
398,179
|
||
|
7
|
SOLE DISPOSITIVE POWER
0 shares
|
||
|
8
|
SHARED DISPOSITIVE POWER
398,179
|
||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
398,179
|
||
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
¨
|
|
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
3.7%
|
||
|
12
|
TYPE OF REPORTING PERSON
PN
|
||
2
CUSIP NO. 045396108
|
1
|
NAME OF REPORTING PERSON
EcoR1 Capital Fund Qualified, L.P.
|
||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) o
(b) o
|
|
|
3
|
SEC USE ONLY
|
||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
0 shares
|
|
|
6
|
SHARED VOTING POWER
563,173
|
||
|
7
|
SOLE DISPOSITIVE POWER
0 shares
|
||
|
8
|
SHARED DISPOSITIVE POWER
563,173
|
||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
563,173
|
||
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
¨
|
|
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.3%
|
||
|
12
|
TYPE OF REPORTING PERSON
PN
|
||
3
CUSIP NO. 045396108
|
1
|
NAME OF REPORTING PERSON
EcoR1 Capital, LLC
|
||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) o
(b) o
|
|
|
3
|
SEC USE ONLY
|
||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
0 shares
|
|
|
6
|
SHARED VOTING POWER
961,352
|
||
|
7
|
SOLE DISPOSITIVE POWER
0 shares
|
||
|
8
|
SHARED DISPOSITIVE POWER
961,352
|
||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
961,352
|
||
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
¨
|
|
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.0%
|
||
|
12
|
TYPE OF REPORTING PERSON
OO
|
||
4
CUSIP NO. 045396108
|
1
|
NAME OF REPORTING PERSON
Oleg Nodelman
|
||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) o
(b) o
|
|
|
3
|
SEC USE ONLY
|
||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
0 shares
|
|
|
6
|
SHARED VOTING POWER
961,352
|
||
|
7
|
SOLE DISPOSITIVE POWER
0 shares
|
||
|
8
|
SHARED DISPOSITIVE POWER
961,352
|
||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
961,352
|
||
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
¨
|
|
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.0%
|
||
|
12
|
TYPE OF REPORTING PERSON
IN
|
||
5
CUSIP NO. 045396108
|
Item 1(a).
|
Name of Issuer:
|
Assembly Biosciences, Inc., a Delaware corporation (the “Issuer”).
|
Item 1(b).
|
Address of Issuer’s Principal Executive Offices:
|
99 Hudson Street, 5th Floor
New York, New York 10013
|
Item 2(a).
|
Name of Person Filing
|
|
Item 2(b).
|
Address of Principal Business Office or, if None, Residence
|
|
Item 2(c).
|
Citizenship
|
EcoR1 Capital Fund, L.P. (“Capital Fund”)
409 Illinois Street
San Francisco, California 94158
Citizenship: Delaware
EcoR1 Capital Fund Qualified, L.P. (“Qualified Fund”)
409 Illinois Street
San Francisco, California 94158
Citizenship: Delaware
EcoR1 Capital, LLC (“EcoR1”)
409 Illinois Street
San Francisco, California 94158
Citizenship: Delaware
Oleg Nodelman
409 Illinois Street
San Francisco, California 94158
Citizenship: United States
Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.”
|
Item 2(d).
|
Title of Class of Securities:
|
Common Stock, $0.001 par value (the “Common Stock”)
|
Item 2(e).
|
CUSIP Number:
|
045396108
|
Item 3.
|
If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
|
|
|
/x/
|
Not applicable.
|
|
|
(a)
|
/ /
|
Broker or dealer registered under Section 15 of the Exchange Act.
|
|
|
(b)
|
/ /
|
Bank as defined in Section 3(a)(6) of the Exchange Act.
|
6
CUSIP NO. 045396108
|
|
(c)
|
/ /
|
Insurance company as defined in Section 3(a)(19) of the Exchange Act.
|
|
|
(d)
|
/ /
|
Investment company registered under Section 8 of the Investment Company Act.
|
|
|
(e)
|
/ /
|
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
|
|
|
(f)
|
/ /
|
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
|
|
|
(g)
|
/ /
|
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
|
|
|
(h)
|
/ /
|
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
|
|
|
(i)
|
/ /
|
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.
|
|
|
(j)
|
/ /
|
Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
|
|
|
(k)
|
/ /
|
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____
|
|
Item 4.
|
Ownership
|
|
|
(a)
|
Amount beneficially owned:
|
As of the close of business on October 7, 2014, Capital Fund directly owned 398,179 shares of Common Stock and Qualified Fund directly owned 563,173 shares of Common Stock. EcoR1, as the general partner of each of Capital Fund and Qualified Fund, may be deemed to beneficially own the 961,352 shares of Common Stock owned in the aggregate by Capital Fund and Qualified Fund. Mr. Nodelman, as the Manager of EcoR1, may be deemed to beneficially own the 961,352 shares of Common Stock owned in the aggregate by Capital Fund and Qualified Fund.
The foregoing should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of any shares of Common Stock owned by another Reporting Person. Each of EcoR1 and Mr. Nodelman disclaims beneficial ownership of the shares of Common Stock directly owned by each of Capital Fund and Qualified Fund and the filing of this statement shall not be construed as an admission that any such person or entity is the beneficial owner of any such securities.
|
|
(b)
|
Percent of class:
|
The following percentages are based on 10,647,059 shares of Common Stock outstanding as of October 1, 2014 based on the Issuer’s Prospectus Supplement filed pursuant to Rule 424(b)(5) with the Securities and Exchange Commission on October 1, 2014.
As of the close of business on October 7, 2014, Capital Fund directly owned approximately 3.7% of the outstanding shares of Common Stock, Qualified Fund directly owned approximately 5.3% of the outstanding shares of Common Stock and each of EcoR1 and Mr. Nodelman may be deemed to beneficially own approximately 9.0% of the outstanding shares of Common Stock.
7
CUSIP NO. 045396108
|
|
(c)
|
Number of shares as to which such person has:
|
|
|
(i)
|
Sole power to vote or to direct the vote
|
See Cover Pages Items 5-9.
|
|
(ii)
|
Shared power to vote or to direct the vote
|
See Cover Pages Items 5-9.
|
|
(iii)
|
Sole power to dispose or to direct the disposition of
|
See Cover Pages Items 5-9.
|
|
(iv)
|
Shared power to dispose or to direct the disposition of
|
See Cover Pages Items 5-9.
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
Not Applicable.
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Not Applicable.
|
Item 7.
|
Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
|
Not Applicable.
|
Item 8.
|
Identification and Classification of Members of the Group.
|
See Exhibit 99.1.
|
Item 9.
|
Notice of Dissolution of Group.
|
Not Applicable.
|
Item 10.
|
Certifications.
|
By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
8
CUSIP NO. 045396108
SIGNATURE
After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
|
Dated: October 8, 2014
|
EcoR1 Capital Fund, L.P.
|
|||
|
By:
|
EcoR1 Capital, LLC
General Partner
|
|||
|
By:
|
/s/ Oleg Nodelman
|
|||
|
Name:
|
Oleg Nodelman
|
|||
|
Title:
|
Manager
|
|||
|
EcoR1 Capital Fund Qualified, L.P.
|
||||
|
By:
|
EcoR1 Capital, LLC
General Partner
|
|||
|
By:
|
/s/ Oleg Nodelman
|
|||
|
Name:
|
Oleg Nodelman
|
|||
|
Title:
|
Manager
|
|||
|
EcoR1 Capital, LLC
|
|||
|
By:
|
/s/ Oleg Nodelman
|
||
|
Name:
|
Oleg Nodelman
|
||
|
Title:
|
Manager
|
||
|
/s/ Oleg Nodelman
|
|
|
Oleg Nodelman
|
9
Exhibit 99.1
Joint Filing Agreement
The undersigned hereby agree that the Statement on Schedule 13G, dated October 8, 2014 with respect to the shares of Common Stock of Assembly Biosciences, Inc. and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
|
Dated: October 8, 2014
|
EcoR1 Capital Fund, L.P.
|
|||
|
By:
|
EcoR1 Capital, LLC
General Partner
|
|||
|
By:
|
/s/ Oleg Nodelman
|
|||
|
Name:
|
Oleg Nodelman
|
|||
|
Title:
|
Manager
|
|||
|
EcoR1 Capital Fund Qualified, L.P.
|
||||
|
By:
|
EcoR1 Capital, LLC
General Partner
|
|||
|
By:
|
/s/ Oleg Nodelman
|
|||
|
Name:
|
Oleg Nodelman
|
|||
|
Title:
|
Manager
|
|||
|
EcoR1 Capital, LLC
|
|||
|
By:
|
/s/ Oleg Nodelman
|
||
|
Name:
|
Oleg Nodelman
|
||
|
Title:
|
Manager
|
||
|
/s/ Oleg Nodelman
|
|
|
Oleg Nodelman
|